Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
July 29, 2025Current Issues in Molecular BiologyOpen Access

Astragaloside IV Ameliorates Cerebral Ischemic-Reperfusion Injury via Improving Mitochondrial Function and Inhibiting Neuronal Apoptosis

View Full Paper
Ask AI
Bookmark
Share

Authors

THTao HeHuazhong Agricultural UniversityXZXiaohong ZhouMinistry of Education of the People's Republic of ChinaXWXiaorong WangSichuan Agricultural University

Discussion

Loading...

Member takes

Overview

Astragaloside IV improves outcomes in cerebral ischemic-reperfusion injury, indicating its therapeutic potential.

Key Points

  • AS-IV shows neuroprotective effects in cerebral ischemic-reperfusion injury by enhancing mitochondrial function.
  • Treatment with AS-IV significantly reduces infarct volume and improves neurological function in a rat model.
  • Molecular assays demonstrate AS-IV upregulates PINK1/Parkin while modulating apoptosis markers Bcl-2 and BAX.
  • Identifying AS-IV's high affinity binding with PINK1/Parkin paves the way for its clinical application in brain injury.

Cite This Study

He et al. (2025) studied this question.

synapsesocial.com/papers/689a093fe6551bb0af8ceca8https://doi.org/10.3390/cimb47080597
View Full Paper
Ask AI
Bookmark
Share